About this medicine
- Approved name
- Ergot-derived dopamine agonists
- International non-proprietary name (INN) or common name
- bromocriptine
- cabergoline
- dihydroergocryptine
- lisuride
- pergolide
About this procedure
- Current status
- European Commission final decision
- Reference number
- CHMP/319054/08
- Type
- Article 31 referrals
This type of referral is triggered when the interest of the Union is involved, following concerns relating to the quality, safety or efficacy of a medicine or a class of medicines.
Key dates and outcomes
- CHMP opinion date
- 26/06/2008